Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
Venkata-Viswanadh Edara, Benjamin A. Pinsky, Mehul S. Suthar, et al.
New England Journal of Medicine (2021) Vol. 385, Iss. 7, pp. 664-666
Open Access | Times Cited: 344

Showing 1-25 of 344 citing articles:

Mechanisms of SARS-CoV-2 entry into cells
Cody B. Jackson, Michael Farzan, Bing Chen, et al.
Nature Reviews Molecular Cell Biology (2021) Vol. 23, Iss. 1, pp. 3-20
Open Access | Times Cited: 2410
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
Nature (2021) Vol. 596, Iss. 7871, pp. 276-280
Open Access | Times Cited: 2013
The biological and clinical significance of emerging SARS-CoV-2 variants
Kaiming Tao, Philip L. Tzou, Janin Nouhin, et al.
Nature Reviews Genetics (2021) Vol. 22, Iss. 12, pp. 757-773
Open Access | Times Cited: 976
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative review
Thibault Fiolet, Yousra Kherabi, Conor-James MacDonald, et al.
Clinical Microbiology and Infection (2021) Vol. 28, Iss. 2, pp. 202-221
Open Access | Times Cited: 820
Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis
Deborah Cromer, Megan Steain, Arnold Reynaldi, et al.
The Lancet Microbe (2021) Vol. 3, Iss. 1, pp. e52-e61
Open Access | Times Cited: 340
Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant
Jun Zhang, Tianshu Xiao, Yongfei Cai, et al.
Science (2021) Vol. 374, Iss. 6573, pp. 1353-1360
Open Access | Times Cited: 289
Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
Science (2021) Vol. 374, Iss. 6575, pp. 1621-1626
Open Access | Times Cited: 285
Reduced sensitivity of infectious SARS-CoV-2 variant B.1.617.2 to monoclonal antibodies and sera from convalescent and vaccinated individuals
Delphine Planas, David Veyer, Artem Baidaliuk, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Closed Access | Times Cited: 278
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Alice Cho, Frauke Muecksch, Dennis Schaefer-Babajew, et al.
Nature (2021) Vol. 600, Iss. 7889, pp. 517-522
Open Access | Times Cited: 274
Overview of the Main Anti-SARS-CoV-2 Vaccines: Mechanism of Action, Efficacy and Safety
Maria Teresa Mascellino, Federica Di Timoteo, Massimiliano De Angelis, et al.
Infection and Drug Resistance (2021) Vol. Volume 14, pp. 3459-3476
Open Access | Times Cited: 241
The germinal centre B cell response to SARS-CoV-2
Brian J. Laidlaw, Ali H. Ellebedy
Nature reviews. Immunology (2021) Vol. 22, Iss. 1, pp. 7-18
Open Access | Times Cited: 213
SARS-CoV-2 Vaccines Based on the Spike Glycoprotein and Implications of New Viral Variants
Daniel Martínez-Flores, Jesús Zepeda–Cervantes, Adolfo Cruz-Reséndiz, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 211
mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron
Matthew Gagné, Juan I. Moliva, Kathryn E. Foulds, et al.
Cell (2022) Vol. 185, Iss. 9, pp. 1556-1571.e18
Open Access | Times Cited: 210
mRNA-1273 and BNT162b2 mRNA vaccines have reduced neutralizing activity against the SARS-CoV-2 omicron variant
Venkata-Viswanadh Edara, Kelly E. Manning, Madison Ellis, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 2, pp. 100529-100529
Open Access | Times Cited: 209
SARS-COV-2 Variants: Differences and Potential of Immune Evasion
Sandro Massao Hirabara, Tamires Duarte Afonso Serdan, Renata Gorjão, et al.
Frontiers in Cellular and Infection Microbiology (2022) Vol. 11
Open Access | Times Cited: 206
Immune responses to two and three doses of the BNT162b2 mRNA vaccine in adults with solid tumors
Rachna T. Shroff, Pavani Chalasani, Ran Wei, et al.
Nature Medicine (2021) Vol. 27, Iss. 11, pp. 2002-2011
Open Access | Times Cited: 192
The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape
Dandan Tian, Yanhong Sun, Jianming Zhou, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 191
Immune Evasion of SARS-CoV-2 Emerging Variants: What Have We Learnt So Far?
Ivana Lazarević, Vera Pravica, Danijela Miljanovic, et al.
Viruses (2021) Vol. 13, Iss. 7, pp. 1192-1192
Open Access | Times Cited: 183
Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission
Alba Escalera, Ana S. González-Reiche, Sadaf Aslam, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 3, pp. 373-387.e7
Open Access | Times Cited: 174
A comprehensive review of SARS-CoV-2 vaccines: Pfizer, Moderna & Johnson & Johnson
Rikinkumar S. Patel, Mohamad Kaki, Venkat Sumanth Potluri, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 1
Open Access | Times Cited: 155
Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant
Kirsten E. Lyke, Robert L. Atmar, Clara Domínguez Islas, et al.
Cell Reports Medicine (2022) Vol. 3, Iss. 7, pp. 100679-100679
Open Access | Times Cited: 144
Germinal center responses to SARS-CoV-2 mRNA vaccines in healthy and immunocompromised individuals
Katlyn Lederer, Emily Bettini, Kalpana Parvathaneni, et al.
Cell (2022) Vol. 185, Iss. 6, pp. 1008-1024.e15
Open Access | Times Cited: 138
Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
Nicole A. Doria‐Rose, Xiaoying Shen, Stephen D. Schmidt, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 123
COVID‐19 vaccinations: The unknowns, challenges, and hopes
Kawthar Mohamed, Piotr Rzymski, Md Shahidul Islam, et al.
Journal of Medical Virology (2021) Vol. 94, Iss. 4, pp. 1336-1349
Open Access | Times Cited: 119
Prior infection with SARS-CoV-2 boosts and broadens Ad26.COV2.S immunogenicity in a variant-dependent manner
Roanne Keeton, Simone I. Richardson, Thandeka Moyo-Gwete, et al.
Cell Host & Microbe (2021) Vol. 29, Iss. 11, pp. 1611-1619.e5
Open Access | Times Cited: 113
Page 1 - Next Page

Scroll to top